Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

Stroke

Volumn 46, Issue 5, 2015, Pages 1321-1327

  Palesch, Yuko Y ^b   Yeatts, Sharon D ^b   Tomsick, Thomas A ^a   Foster, Lydia D ^b   Demchuk, Andrew M ^c   Khatri, Pooja ^a   Hill, Michael D ^c   Jauch, Edward C ^b   Jovin, Tudor G ^d   Yan, Bernard ^e   Von Kummer, Rüdiger ^f   Molina, Carlos A ^g   Goyal, Mayank ^c   Schonewille, Wouter J ^h,i   Mazighi, Mikael ^j   Engelter, Stefan T ^k   Anderson, Craig ^l   Spilker, Judith ^a   Carrozzella, Janice ^a   Ryckborst, Karla J ^c   Janis, L Scott ^m   Simpson, Annie ^b   Simpson, Kit N ^b   Broderick, Joseph P ^a   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ ST ANTONIUS HOSPITAL   (Netherlands)

^j HÔPITAL LARIBOISIÈRE   (France)

^k UNIVERSITY HOSPITAL BASEL   (Switzerland)

^l ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^m NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

more..

Author keywords

acute stroke; endovascular procedures; randomized trial; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ALBERTA STROKE PROGRAM EARLY CT SCORE; ARTICLE; ASSESSMENT OF HUMANS; AUSTRALIA; BASILAR ARTERY OBSTRUCTION; CANADA; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOVASCULAR SURGERY; EUROPE; EUROQOL 5D 3L; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OPEN STUDY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STROKE PATIENT; UNITED STATES; ADOLESCENT; CLINICAL TRIAL; COHORT ANALYSIS; CONVALESCENCE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; MALE; MIDDLE AGED; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RECOVERY OF FUNCTION; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84937231291     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009180     Document Type: Article

References (33)

1. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous tPA versus tPA alone for stroke. N Engl J Med. 2013;368:893-903. doi: 10.1056/NEJMoa1214300.
2. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, et al; Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008;3:130-137. doi: 10.1111/j.1747-4949.2008.00151.x.
3. Mauldin PD, Simpson KN, Palesch YY, Spilker JS, Hill MD, Khatri P, et al; Interventional Management of Stroke III Investigators. Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008;3:138-144. doi: 10.1111/j.1747-4949.2008.00190.x.
4. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
5. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16:199-208.
6. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-343.
7. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.
8. Pickard AS, Johnson JA, Feeny DH, Shuaib A, Carriere KC, Nasser AM. Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke. 2004;35:607-612. doi: 10.1161/01.STR.0000110984.91157.B.D.
9. Chapter 6. In: Drummond MF, Schulpher MJ, Torrance GW, O'Brian B, Stoddard GL, eds. Methods for the Economic Evaluation of Health Care Programs. Oxford, UK: Oxford University Press; 2005:177-183.
10. Chernyak N, Sattel H, Scheer M, Baechle C, Kruse J, Henningsen P, et al. Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder. PLoS One. 2014;9:e83894. doi: 10.1371/journal.pone.0083894. 11. Chapter 4 and
11. Chapter 4 and In: McCullagh P, Nelder J, eds. Generalized Linear Models. 2nd ed. London: Chapman and Hall; 1989:98-184.
12. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674.
13. NINDS rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-1587.
14. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004; 35:904-911.
15. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11-20. doi: 10.1056/NEJMoa1411587.
16. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. for the ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030. doi: 10.1056/NEJMoa1414905.
17. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al; for the EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792.
18. Mackey J, Khatri P, Broderick JP; IMS III Investigators. Increasing use of CT angiography in interventional study sites: the IMS III experience. AJNR Am J Neuroradiol. 2010;31:E34. doi: 10.3174/ajnr.A1996.
19. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
20. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36:2121-2125. doi: 10.1161/01. STR.0000182099.04994.f.c.
21. Nakajima M, Kimura K, Ogata T, Takada T, Uchino M, Minematsu K. Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol. 2004;25:238-241.
22. Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, et al; IMS III Investigators. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014;273:202-210. doi: 10.1148/radiol.14132649.
23. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005;36:1700-1704. doi: 10.1161/01. STR.0000173407.40773.17.
24. Saake M, Breuer L, Gölitz P, Köhrmann M, Schwab S, Dörfler A, et al. Clinical/perfusion CT CBV mismatch as prognostic factor in intraarterial thrombectomy in acute anterior circulation stroke. Clin Neurol Neurosurg. 2014;121:39-45. doi: 10.1016/j.clineuro.2014.03.007.
25. Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, et al; IMS III Trialists. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014;13:567-574. doi: 10.1016/S1474-4422(14)70066-3.
26. Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 2013;127:1980-1985. doi: 10.1161/CIRCULATIONAHA.112.000311.
27. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al; ECASS, ATLANTIS, NINDS and EPITHET rtPA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703. doi: 10.1016/S0140-6736(10)60491-6.
28. Barnes B, Hanley DF, Carhuapoma JR. Minimally invasive surgery for intracerebral haemorrhage. Curr Opin Crit Care. 2014;20:148-152. doi: 10.1097/MCC.0000000000000077.
29. Wilson DA, Nakaji P, Albuquerque FC, McDougall CG, Zabramski JM, Spetzler RF. Time course of recovery following poor-grade SAH: the incidence of delayed improvement and implications for SAH outcome study design. J Neurosurg. 2013;119:606-612. doi: 10.3171/2013.4.JNS121287.
30. Kong KH, Lee J. Temporal recovery and predictors of upper limb dexterity in the first year of stroke: a prospective study of patients admitted to a rehabilitation centre. NeuroRehabilitation. 2013;32:345-350. doi: 10.3233/NRE-130854.
31. Bruno A, Akinwuntan AE, Lin C, Close B, Davis K, Baute V, et al. Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke. 2011;42:2276-2279. doi: 10.1161/STROKEAHA.111.613273.
32. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249. doi: 10.1016/S0140-6736(12)61384-1.
33. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240. doi: 10.1016/S0140-6736(12)61299-9.